Effects of 0.05% racanisodamine on pupil size and accommodation

Optometry and Vision Science

Volumn 87, Issue 12, 2010, Pages 966-970

  Chen, Zhi ^a   Li, Tao ^a   Yao, Peijun ^a   Xu, Ye ^a   Zhou, Xingtao ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

accommodation; eye drop; myopia; pupil size; Racanisodamine

Indexed keywords

ACCOMMODATION; EYE DROPS; MYOPIA; PUPIL SIZE; RACANISODAMINE;

OPHTHALMOLOGY; REGRESSION ANALYSIS; SURVEYS;

DROPS;

ANISODAMINE; ATROPINE; DIAGNOSTIC AGENT; EYE DROPS; MUSCARINIC RECEPTOR BLOCKING AGENT; SOLANUM ALKALOID;

ACCOMMODATION; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECT; EYE REFRACTION; HUMAN; INFRARED RADIATION; MYOPIA; PATHOPHYSIOLOGY; PHOTOPHOBIA; PUPIL; TIME;

ACCOMMODATION, OCULAR; ATROPINE; CHILD; DISEASE PROGRESSION; HUMANS; INFRARED RAYS; MUSCARINIC ANTAGONISTS; MYOPIA; OPHTHALMIC SOLUTIONS; PHOTOPHOBIA; PUPIL; REFRACTION, OCULAR; SOLANACEOUS ALKALOIDS; TIME FACTORS;

EID: 78650586392     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/OPX.0b013e3181fc6445     Document Type: Conference Paper

References (31)

1. Vitale S, Sperduto RD, Ferris FL III. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol 2009;127:1632-9.
2. Bedrossian RH. The effect of atropine on myopia. Ophthalmology 1979;86:713-9.
3. Brodstein RS, Brodstein DE, Olson RJ, Hunt SC, Williams RR. The treatment of myopia with atropine and bifocals. A long-term prospective study. Ophthalmology 1984;91:1373-9.
4. Chou AC, Shih YF, Ho TC, Lin LL. The effectiveness of 0.5% atropine in controlling high myopia in children. J Ocul Pharmacol Ther 1997;13:61-7.
5. Yen MY, Liu JH, Kao SC, Shiao CH. Comparison of the effect of atropine and cyclopentolate on myopia. Ann Ophthalmol 1989;21: 180-2, 187.
6. Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res 2005;30:71-80.
7. Hasebe S, Ohtsuki H, Nonaka T, Nakatsuka C, Miyata M, Hamasaki I, Kimura S. Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double-masked, crossover trial. Invest Ophthalmol Vis Sci 2008;49:2781-9.
8. Walline JJ, Jones LA, Mutti DO, Zadnik K. A randomized trial of the effects of rigid contact lenses on myopia progression. Arch Ophthalmol 2004;122:1760-6.
9. Lind GJ, Chew SJ, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci 1998;39:2217-31.
10. Schwahn HN, Kaymak H, Schaeffel F. Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick. Vis Neurosci 2000;17:165-76.
11. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 1993;34:205-15.
12. McKanna JA, Casagrande VA. Atropine affects lid suture myopic development. Doc Ophthalmol 1981;28:187-92.
13. Young FA. The effect of atropine on the development of myopia in monkeys. Am J Optom Arch Am Acad Optom 1965;42:439-49.
14. Tigges M, Iuvone PM, Fernandes A, Sugrue MF, Mallorga PJ, Laties AM, Stone RA. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci 1999;76:397-407.
15. Barathi VA, Beuerman RW, Schaeffel F. Effects of unilateral topical atropine on binocular pupil responses and eye growth in mice. Vision Res 2009;49:383-7.
16. Fan DS, Lam DS, Chan CK, Fan AH, Cheung EY, Rao SK. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study. Jpn J Ophthalmol 2007;51:27-33.
17. Shih YF, Hsiao CK, Chen CJ, Chang CW, Hung PT, Lin LL. An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression. Acta Ophthalmol Scand 2001;79: 233-6.
18. Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia. Exp Eye Res 1991;52:755-8.
19. Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 1989;35:469-76.
20. Cottriall CL, McBrien NA. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest Ophthalmol Vis Sci 1996;37:1368-79.
21. Cottriall CL, McBrien NA, Annies R, Leech EM. Prevention of formdeprivation myopia with pirenzepine: a study of drug delivery and distribution. Ophthalmic Physiol Opt 1999;19:327-35.
22. Siatkowski RM, Cotter SA, Crockett RS, Miller JM, Novack GD, Zadnik K. Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. J AAPOS 2008; 12:332-9.
23. Truong HT, Cottriall CL, Gentle A, McBrien NA. Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism. Exp Eye Res 2002;74:103-11.
24. Cottriall CL, Truong HT, McBrien NA. Inhibition of myopia development in chicks using himbacine: a role for M(4) receptors? Neuroreport 2001;12:2453-6.
25. Yuan H, Wang Y, Liu Y. Progress in pharmacological research of anisodamine. Mod J Integr Trad Chin West Med 2004;13:2210-1.
26. He X. [Pharmacological effect of anisodamine and mechanism study.] J Math Med 1998;11:250-1.
27. Lin JW, Zou YF. [Methods of determination of racanisodamine eye drops.] Mod Med Health 2008;24:1083.
28. Chen JC, Deng DM, Mai GH. [Raceanisodamine eye drops for the treatment of childhood myopia.] Chin J Opto Ophthalmol 2009;11: 469-471.
29. Rapp LM, Tolman BL, Dhindsa HS. Separate mechanisms for retinal damage by ultraviolet-A and mid-visible light. Invest Ophthalmol Vis Sci 1990;31:1186-90.
30. Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 1999;15:85-90.
31. Smith EL III, Redburn DA, Harwerth RS, Maguire GW. Permanent alterations in muscarinic receptors and pupil size produced by chronic atropinization in kittens. Invest Ophthalmol Vis Sci 1984;25:239-43.